Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

PURPOSE: This study was designed to determine (1) rates of clinically meaningful tumor reduction in breast tumor size following neoadjuvant chemotherapy (NAC), (2) which receptor subtypes and MRI phenotypes are associated with clinically meaningful tumor reduction, and (3) whether MRI phenotype impa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mukhtar, Rita A., Yau, Christina, Rosen, Mark, Tandon, Vickram J., Hylton, Nola, Esserman, Laura J.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2013
Assuntos:
Breast Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824937/
https://ncbi.nlm.nih.gov/pubmed/23780381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3038-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares